- $1.28bn
- $1.72bn
- $348.97m
Brief: MannKind To Acquire scPharmaceuticals
Brief: MannKind And Blackstone Announce Up To $500 Million Strategic Financing Agreement
MannKind Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: MannKind Q2 Operating Income USD 5.299 Million
Health Rounds: Inhaled insulin as good as injection for children at mealtime
MannKind Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: MannKind Q1 Total Revenue USD 78 Million Vs. IBES Estimate USD 76.1 Million
MannKind Corp expected to post earnings of 4 cents a share - Earnings Preview
MannKind Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: MannKind Files For Mixed Shelf - SEC Filing
Brief: MannKind Q4 Pretax Profit USD 8.445 Million
Brief: MannKind Expands Executive Leadership Team
U.S. RESEARCH ROUNDUP- Amazon, Mastercard, Tesla
U.S. STOCKS ON THE MOVE-Gold miners, Tesla, ADM
U.S. STOCKS ON THE MOVE-Candel Therapeutics, Broadcom, Reddit
U.S. STOCKS ON THE MOVE-Exxon Mobil, Mondelez International, Macy's
MannKind rises after India approves insulin inhalation powder
MannKind Corp reports results for the quarter ended in September 30 - Earnings Summary
MannKind Corp expected to post earnings of 3 cents a share - Earnings Preview